)
Visual21 Nov 2025
Data center suppliers
Journey Medical Corp (DERM) investor relations material
Journey Medical Corp Q3 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2025 earnings summary12 Nov, 2025
Executive summary
Q3 2025 revenue grew 21% year-over-year to $17.6 million, driven by the U.S. launch of Emrosi, which contributed $4.9 million and saw 146% sequential prescription growth.
Legacy products (Qbrexza, Accutane, ZILXI) were flat sequentially but declined year-over-year due to generic competition.
Net loss for Q3 2025 was $2.3 million ($0.09 per share), a slight improvement from $2.4 million ($0.12 per share) in Q3 2024.
For the nine months ended September 30, 2025, total revenue rose 8% to $45.8 million, with Emrosi contributing $9.7 million.
Clinical data confirmed Emrosi's statistically significant efficacy over Oracea and placebo for rosacea treatment.
Financial highlights
Q3 2025 total revenue was $17.6 million, up from $14.9 million in Q3 2024; product revenue was $17.0 million.
Gross margin reached 67.4% in Q3 2025, up from 67.1% in Q2 and 63.5% in Q1, but below 69.4% in Q3 2024.
Adjusted EBITDA was positive at $1.7 million, up from $0.3 million in Q3 2024; EBITDA loss narrowed to $0.5 million from $1.0 million.
Cash and cash equivalents stood at $24.9 million as of September 30, 2025, up from $20.3 million at year-end 2024.
Operating expenses for Q3 2025 were $19.2 million, up 9% year-over-year, mainly from Emrosi launch activities.
Outlook and guidance
Management expects to become sustainably EBITDA positive in Q4 2025, with Emrosi projected to reach peak annual net sales of over $200 million in the U.S. and $300 million globally.
Operating expenses are anticipated to remain relatively consistent as revenue grows, supporting operating leverage into 2026.
Substantial doubt exists about the ability to continue as a going concern for at least twelve months due to recurring losses.
The company may seek additional capital through debt or equity financings and continues to evaluate strategic alternatives.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Journey Medical Corp earnings date
Q4 202525 Mar, 2026
Next Journey Medical Corp earnings date
Q4 202525 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Journey Medical Corporation is a pharmaceutical company specializing in dermatological treatments. Its focus is on developing and commercializing products to address various skin conditions. The company's portfolio includes branded and generic prescription medications, such as Qbrexza, a medicated cloth for hyperhidrosis, and Accutane, a well-known oral treatment for severe acne. Other offerings include Amzeeq and Zilxi, both topical minocycline formulations for acne and rosacea, respectively, and Exelderm, an antifungal cream. The company is headquartered in Scottsdale, Arizona, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage